Outlook Therapeutics stock jumps ahead of FDA's Dec. 31 Lytenava decision

Outlook Therapeutics stock jumps ahead of FDA's Dec. 31 Lytenava decision

Download Media Asset of Outlook Therapeutics stock jumps ahead of FDA's Dec. 31 Lytenava decision

View / Download Original

High Res (1920p) Standard (1280p) Web Proxy (800p)

Opens image in a new tab. Right-click → Save As to download.

This media asset is an official release provided by Visit California Tourism Board for the destination guide Outlook Therapeutics. Authorized for editorial and promotional use. See Usage Rights.

← Return to Press Kit